BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33680977)

  • 1. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
    Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
    Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
    Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
    Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
    Wang MS; Wang JL; Wang XF
    BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of interferon gamma release assays in patients with nontuberculous mycobacterial infection: a systematic review and meta-analysis.
    Guan CP; Wu YH; Wang XF; He Y; Zhang YA; Wang MS
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1251-1262. PubMed ID: 37702955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California.
    Lu J; Murugesan K; Senchyna F; Budvytiene I; Banaei N
    J Clin Microbiol; 2023 Nov; 61(11):e0077523. PubMed ID: 37843251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.
    Siegel SAR; Cavanaugh M; Ku JH; Kawamura LM; Winthrop KL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
    Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
    J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease.
    Jia H; Pan L; Wang G; Duan H; Song Z; Sun Q; Wei R; Du B; Xing A; Zhang Z
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adjusted cut-offs of interferon-γ release assays on diagnosis of tuberculosis in patients with fever of unknown origin.
    Shen Y; Qi X; Wu J; Gao Y; Shao L; Zhang W; Wang S
    J Clin Tuberc Other Mycobact Dis; 2022 Feb; 26():100290. PubMed ID: 35005253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.
    Hermansen TS; Thomsen VØ; Lillebaek T; Ravn P
    PLoS One; 2014; 9(4):e93986. PubMed ID: 24705675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
    Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
    Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Interferon-γ Release Assays in Patients with
    Gao CH; Zhang YA; Wang MS
    Infect Drug Resist; 2022; 15():7727-7732. PubMed ID: 36597452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a model for the differential diagnosis of non-tuberculous mycobacterial lung disease and pulmonary tuberculosis: A case-control study based on immunological and radiological features.
    Liu Q; Pan X; An H; Du J; Li X; Sun W; Gao Y; Li Y; Niu H; Gong W; Liang J
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111064. PubMed ID: 37857122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India.
    Thangavelu K; Krishnakumariamma K; Pallam G; Dharm Prakash D; Chandrashekar L; Kalaiarasan E; Das S; Muthuraj M; Joseph NM
    J Infect Public Health; 2021 Mar; 14(3):320-323. PubMed ID: 33618276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Interferon-γ Release Assays Be Useful for Monitoring the Response to Anti-tuberculosis Treatment?: A Systematic Review and Meta-analysis.
    Pourakbari B; Mamishi S; Benvari S; Sauzullo I; Bedini A; Valentini P; Keicho N; Mahmoudi S
    Arch Immunol Ther Exp (Warsz); 2020 Feb; 68(1):4. PubMed ID: 32016610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Detjen AK; Keil T; Roll S; Hauer B; Mauch H; Wahn U; Magdorf K
    Clin Infect Dis; 2007 Aug; 45(3):322-8. PubMed ID: 17599309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.